Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors

Authors: Reduzzi, Carolina, Nicolo’, Eleonora, Singhal, Surbhi, Venetis, Konstantinos, Ortega-Franco, Ana, de Miguel-Perez, Diego, Dipasquale, Angelo, Gouda, Mohamed A., Saldanha, Erick F., Kasi, Pashtoon M., Jantus-Lewintre, Eloisa, Fusco, Nicola, Malapelle, Umberto, Gandara, David R., Rolfo, Christian, Serrano, Maria Jose, Cristofanilli, Massimo

Source: In Critical Reviews in Oncology / Hematology November 2024 203

First-Line Immune Checkpoint Inhibition for Advanced Non-Small-Cell Lung Cancer: State of the Art and Future Directions

Authors: Ackermann, Christoph Jakob, Adderley, Helen, Ortega-Franco, Ana, Khan, Adeel, Reck, Martin, Califano, Raffaele

Source: Drugs. 80(17):1783-1797

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183437869.0x000001&indx=1&recIds=ETOCvdc_100183437869.0x000001

The role of liquid biopsy as a catalyst for sustained progress in precision oncology – Perspective of the young committee of the international society of liquid biopsy

Authors: Saldanha, Erick F., Nicolo, Eleonora, Venetis, Konstantinos, de Miguel-Perez, Diego, Ortega-Franco, Ana, Dipasquale, Angelo, Gouda, Mohamed A., Singhal, Surbhi, Adigbli, George, Reduzzi, Carolina

Source: In The Journal of Liquid Biopsy September 2024 5

Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Authors: Osborne, Lucy, Ortega-Franco, Ana, Hodgson, Clare, Pearce, Mark, Moss, Anna, Lindsay, Colin, Hughes, Sarah, Taylor, Paul, Califano, Raffaele, Rafee, Shereen, Gomes, Fabio, Summers, Yvonne, Blackhall, Fiona, Cove-Smith, Laura, Halkyard, Emma, Fenemore, Jackie

Source: Lung cancer. 165(S1):S46-S46

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100155622823.0x000001&indx=1&recIds=ETOCvdc_100155622823.0x000001

Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index.

Authors: Ortega-Franco, Ana, Hodgson, Clare, Raja, Haseem, Carter, Mathew, Lindsay, Colin, Hughes, Sarah, Cove-Smith, Laura, Taylor, Paul, Summers, Yvonne, Blackhall, Fiona, Califano, Raffaele

Source: Targeted Oncology; Jul2022, Vol. 17 Issue 4, p453-465, 13p

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer.

Authors: Ortega-Franco, Ana, Rafee, Shereen

Source: Oncology & Therapy; Jun2022, Vol. 10 Issue 1, p13-22, 10p

Subject Terms: LUNG cancer prognosis, ADJUVANT chemotherapy, BIOMARKERS, GENETIC mutation, ONCOGENES, EPIDERMAL growth factor receptors, TREATMENT duration, PROTEIN-tyrosine kinase inhibitors, COST effectiveness

97 - Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Authors: Osborne, Lucy, Ortega-Franco, Ana, Hodgson, Clare, Pearce, Mark, Moss, Anna, Lindsay, Colin, Hughes, Sarah, Taylor, Paul, Califano, Raffaele, Rafee, Shereen, Gomes, Fabio, Summers, Yvonne, Blackhall, Fiona, Cove-Smith, Laura, Halkyard, Emma, Fenemore, Jackie

Source: In Lung Cancer March 2022 165 Supplement 1:S46-S46

P-059 - Radical chemoradiotherapy for patients with locally advanced esophageal cancer. Long-term follow up of an ambispective study

Authors: Bergamino Sirven, Milana, Ortega Franco, Ana, Hormigo, Gloria, Aliste, Luisa, Padrol, Isabel, Rizzo, Manglio, Calvo, Mariona, Serra, Òlbia, Virgili, Núria, Creus, Glòria, Boladeras Ana, Maria, Farran, Leandre, Domenech Viñolas, Marta, Molina, Kevin, Borràs Josep, Maria, Galán, Maica

Source: In Annals of Oncology June 2017 28 Supplement 3:iii29-iii29